(SPIN) Spine Injury Solutions - Ratings and Ratios

Spine Injury Solutions Inc (BATS:SPIN) is a US-based healthcare services company that operates in the specialized field of spine injury treatment. The companys investment strategy typically allocates 80% of its net assets to a mix of US equity securities and premium income-generating investments, and is classified as non-diversified, indicating a concentrated investment approach.

With a market presence on BATS, the companys stock is traded as a common stock, and its operations are rooted in the US healthcare services sector, specifically within the Health Care Services sub-industry as per GICS classification. For more information on the companys operations and services, one can visit their website at https://www.bitech.tech.

From a technical analysis perspective, SPINs stock price is currently at $28.66, slightly above its 20-day Simple Moving Average (SMA) of $28.51 and 50-day SMA of $28.01, indicating a potential bullish trend in the short to medium term. However, the stock is below its 200-day SMA of $29.11, suggesting a longer-term bearish trend. The Average True Range (ATR) is $0.24, representing a daily volatility of 0.84%. The stocks 52-week high and low are $30.52 and $25.38, respectively, showing the price range over the past year.

Fundamentally, Spine Injury Solutions Inc has a market capitalization of $3.37 million, indicating a small-cap company. The Price-to-Earnings (P/E) ratio is 24.95, suggesting that the stock may be relatively expensive compared to its earnings. The absence of a forward P/E ratio complicates future earnings expectations. Moreover, the Return on Equity (RoE) is -16.88%, indicating negative profitability from shareholders perspective.

Forecasting the future performance of SPIN involves analyzing both technical and fundamental data. Given the current technical indicators, if the stock continues to trade above its 20-day and 50-day SMAs, it may indicate a short-term upward trend. However, the stocks position below its 200-day SMA and the negative RoE are cautionary signs. Assuming the company can improve its profitability, a potential target price could be near its 52-week high of $30.52, representing a 6.5% increase from the current price. Conversely, failure to address the negative RoE could lead to a decline towards the 52-week low of $25.38, a drop of approximately 11.5% from current levels.